查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2006519

製药生产设备市场：按设备类型、技术、最终用户和应用划分－2026-2032年全球市场预测

Pharmaceutical Manufacturing Equipment Market by Equipment Type, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，製药生产设备市场价值将达到 205.5 亿美元，到 2026 年将成长至 219.7 亿美元，到 2032 年将达到 335.6 亿美元，复合年增长率为 7.26%。

主要市场统计数据
基准年 2025 205.5亿美元
预计年份：2026年 219.7亿美元
预测年份 2032 335.6亿美元
复合年增长率 (%) 7.26%

製药生产设施是药物研发和生产的核心，能够将复杂的製剂转化为安全有效的治疗药物。随着行业面临不断变化的监管要求、日益增长的生物製药需求以及优化成本和缩短上市时间的迫切需要，设施的选择和整合已成为至关重要的战略挑战。各生产设施正在投资高精度压片压平机、先进的层析法设备和先进的生物反应器，以支援无菌生产流程。这些投资不仅能够提高製程控制和产品品质，还能增强营运柔软性，进而满足个人化医疗和小批量生产的需求。

近年来，细胞疗法和基因疗法等新型治疗方法的出现，进一步提升了专用发酵槽、一次性混合器和冷冻干燥机等设备的重要性，这些设备能够快速规模化生产。同时，传统的固态製剂系统也不断发展，自动化製粒机和流化床干燥机的引入，使得颗粒尺寸分布更加精确，包衣更加均匀。因此，生命科学公司优先考虑整合数位化监控、预测性维护和模组化架构的设备解决方案。这种综合方法使生产线能够在保持严格合规性的同时，快速切换不同的产品系列。

展望未来，至关重要的是要了解这些技术进步如何与不断变化的市场动态和监管环境相互作用。以下章节将检验正在重塑医疗器材领域的变革性变化，并为评估这些新趋势的策略意义奠定基础。

因应颠覆性的技术和监管变革：重新定义製药设施的效率和扩充性。

在自动化、数位化和监管要求的推动下，製药器材产业正经历着一场翻天覆地的变革。人工智慧驱动的自动化平台简化了从胶囊填充到片剂包衣等复杂的生产流程，并即时优化程式参数。同时，资料驱动的品质源自于设计 (QbD) 框架正在取代传统的批次放行通讯协定，从而实现主动控制策略，最大限度地减少偏差，确保产品特性的一致性。

评估美国2025年关税对製药设备供应链的多方面影响。

美国将于2025年实施的新关税政策，为製药生产设备的采购和部署带来了显着的复杂性。随着进口机械和关键耗材关税的提高，製造商面临更高的资本投入和更长的交货前置作业时间。这些成本压力促使企业重新评估其供应商策略，并探索在免税地区在地化生产流体化床干燥机、发酵槽和层析法设备的方案。

透过按设备、技术、最终用户和应用进行详细的細項分析，揭示了关键的市场动态。

精准的市场区隔对于制定製药设备产业的策略重点至关重要。在考虑设备类型时，必须将无菌加工设备、泡壳包装机、胶囊填充机、层析法设备、发酵槽和生物反应器、流体化床干燥机、製粒机、液体填充机、冷冻干燥机、混合机和片剂加工系统纳入考量，其中片剂包衣机和压压平机是重要的子类别。在技​​术细分方面，可重复使用设备因其耐用性和成本摊销而备受青睐，而一次性设备则因其柔软性和减少清洁验证工作量而更具优势。

区域市场分析：揭示美洲、欧洲、中东和非洲以及亚太地区的成长要素和战略机会

区域趋势在塑造製药生产设备产业的未来发挥决定性作用。在美洲，强大的生物製药开发平臺和政府对国内生产的奖励，刺激了对一次性生物反应器、层析法系统和冷冻干燥平台的强劲需求。北美的主要生产基地正在利用先进的分析技术和自动化手段对现有设施进行现代化改造，从而延长设备使用寿命并降低营运成本。

确定影响产业竞争力的关键製药生产设备供应商及其策略措施。

领先的设备供应商透过结合内部创新、策略伙伴关係和有针对性的收购来脱颖而出。一些全球性公司正在透过收购无菌连接器和过滤装置的细分市场製造商来扩展其一次性产品组合，从而为终端用户提供更全面的即插即用解决方案。另一些公司则在投资数位双胞胎和云端监控平台，使製程工程师能够在无需进行实际测试的情况下模拟放大场景并排查设备效能问题。

为行业领导者提供提升营运敏捷性和推动永续成长的实用策略和最佳实践

行业领导者应优先考虑柔软性和数位化集成，以保持竞争力。投资模组化、一次性系统有助于缩短验证週期，并实现产品线之间的快速切换，从而促进向个人化治疗的过渡。将硬体升级与先进的製程控制软体结合，可即时掌握关键参数，使团队能够主动预防偏差，并保持稳定的产品品质。

一项全面的研究途径，详细说明了支撑研究可靠性的资料收集、检验和分析方法。

本研究采用严谨的研究架构，结合一手访谈、二手资料分析及量化检验方法。与製程工程师、品质保证经理和采购人员的专家讨论，为了解设备性能、维护实务和策略性投资驱动因素提供了第一手资料。除访谈外，透过广泛查阅行业出版物、技术规范和监管指南，确保对市场趋势的全面理解。

总结主要发现及其对全球製药设备行业相关人员的战略意义的结论。

本执行摘要阐述了先进製药生产设备在支援稳健且高效的药品生产中发挥的关键作用。透过探讨从自动化和一次性技术到贸易政策影响等变革性趋势，相关人员可以更准确地了解日益复杂的产业格局。细分市场分析揭示了不同设备类型、技术偏好、终端用户类别和应用领域的需求差异，并强调了针对每个行业制定客製化策略的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 製药生产设备市场：依设备类型划分

  • 无菌加工设备
  • 泡壳包装机
  • 胶囊填充装置
  • 层析法装置
  • 发酵槽和生物反应器
  • 流体化床干燥器
  • 造粒机
  • 液体填充机
  • 冷冻干燥机
  • 混合器
  • 片剂生产设备
    • 片剂包衣机
    • 压平机片机

第九章 製药生产设备市场：依技术划分

  • 可重复使用设备
  • 免洗设备

第十章 製药生产设备市场：依最终用户划分

  • 契约製造组织
  • 製药公司
  • 研究和学术机构
  • 研究机构

第十一章 製药生产设备市场：依应用领域划分

  • 无菌灌装
  • 生物製药生产
  • 口服液体製剂的生产
  • 注射剂的生产
  • 固态剂型的生产

第十二章 製药生产设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 製药生产设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 製药生产设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国製药生产设备市场

第十六章：中国製药设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ACG Pvt. Ltd.
  • ACIC Pharmaceuticals Inc.
  • Alfa Laval AB
  • Ambica Pharma Machines Pvt. Ltd.
  • GEA Group Aktiengesellschaft
  • Glatt GmbH
  • IDEX Corporation
  • IMA Group
  • Jinhu Ginhong Machinery Co., Ltd.
  • Komachine Inc.
  • Korber AG
  • Lee Industries
  • Maquinaria Industrial Dara, SL
  • Marchesini Group SpA
  • MG2 srl
  • Niverplast BV
  • Paul Mueller Company
  • Romaco Group
  • Shinva Medical Instrument Co., Ltd.
  • Solvay SA
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.
  • UNITED PHARMATEK LLC
Product Code: MRR-961BA04A2E92

The Pharmaceutical Manufacturing Equipment Market was valued at USD 20.55 billion in 2025 and is projected to grow to USD 21.97 billion in 2026, with a CAGR of 7.26%, reaching USD 33.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.55 billion
Estimated Year [2026] USD 21.97 billion
Forecast Year [2032] USD 33.56 billion
CAGR (%) 7.26%

Pharmaceutical manufacturing equipment sits at the heart of drug development and production, enabling the translation of complex formulations into safe, effective therapies. As the industry contends with evolving regulatory requirements, rising demand for biologics, and the imperative to optimize cost and time to market, equipment selection and integration have become critical strategic considerations. Facilities are investing in high-precision tablet presses, state-of-the-art chromatography suites, and advanced bioreactors that support aseptic processing. These investments not only enhance process control and product quality but also foster the operational flexibility needed to address personalized medicine and small-batch production.

In recent years, the entry of novel therapeutic modalities such as cell and gene therapies has further elevated the role of specialized fermenters, single-use mixers, and lyophilizers in enabling rapid scale-up. Meanwhile, traditional solid dosage systems have continued to evolve, featuring automated granulators and fluid bed dryers that deliver tighter particle size distribution and uniform coating. Consequently, life science companies are prioritizing equipment solutions that integrate digital monitoring, predictive maintenance, and modular architectures. This holistic approach ensures that manufacturing lines can pivot swiftly between diverse product portfolios while maintaining rigorous compliance.

Looking ahead, understanding how these technological advancements intersect with shifting market dynamics and regulatory environments will be essential. The following section examines the transformative shifts reshaping the pharmaceutical equipment landscape and sets the stage for assessing the strategic implications of emerging trends.

Navigating Disruptive Technological and Regulatory Transformations Redefining Pharmaceutical Equipment Efficiency and Scalability

The pharmaceutical equipment landscape is undergoing seismic transformation as advances in automation, digitalization, and regulatory expectations converge. Automation platforms embedded with artificial intelligence are streamlining complex workflows, from capsule filling to tablet coating, by optimizing process parameters in real time. Concurrently, data-driven quality by design frameworks are replacing traditional batch release protocols, enabling proactive control strategies that minimize deviations and ensure consistent product attributes.

Single-use technologies have moved beyond niche applications to become mainstream, particularly in biopharmaceutical manufacturing environments where contamination risks and cleaning validation costs drive demand for disposable systems. This shift has challenged equipment manufacturers to expand their portfolios to include sterile connectors, prevalidated assemblies, and modular fluid handling units. In parallel, continuous processing architectures are gaining traction for both small molecule and biologic production, promising reduced footprint, lower energy consumption, and improved yield stability.

Regulatory agencies across key markets are also reshaping the landscape. Recent guidance has emphasized process analytical technologies, real-time release testing, and lifecycle management practices, compelling equipment suppliers and end users to collaborate early in development. Supply chain resilience has emerged as another critical axis of transformation, with firms diversifying component sourcing and exploring nearshoring strategies to mitigate geopolitical uncertainties. Taken together, these disruptive forces are redefining efficiency, scalability, and risk management in pharmaceutical manufacturing.

Assessing the Multifaceted Consequences of United States Tariffs on Pharmaceutical Manufacturing Equipment Supply Chains in 2025

The implementation of new United States tariffs in 2025 has introduced significant complexity to the procurement and deployment of pharmaceutical manufacturing equipment. As duties increase on imported machinery and critical consumables, manufacturers have encountered rising capital expenditure requirements and extended lead times. These cost pressures have prompted organizations to reassess supplier strategies, exploring options to localize production of fluid bed dryers, fermenters, and chromatography units in tariff-free jurisdictions.

The ramifications extend beyond direct cost increases. Equipment vendors facing higher import duties are recalibrating pricing models and, in some cases, shifting inventory buffers to domestic warehouses. End users have responded by grouping orders into larger shipments to dilute tariff impacts or renegotiating long-term service contracts to secure fixed pricing. Meanwhile, the threat of further trade restrictions has accelerated interest in distributed manufacturing networks, where modular tablet processing and liquid filling systems can be deployed closer to end markets.

Despite these challenges, strategic adaptation has unlocked opportunities for equipment innovators. Firms that have invested in local engineering capabilities and decentralized assembly facilities are better positioned to maintain delivery timelines and preserve margins. Moreover, the tariffs have intensified collaboration between manufacturers and financial services providers, leading to creative leasing structures and equipment-as-a-service offerings that defer upfront capital outlay. Ultimately, navigating the 2025 tariff environment will demand agility, foresight, and the willingness to embrace alternative procurement models.

Uncovering Critical Market Dynamics through Detailed Equipment, Technology, End User, and Application Segmentation Insights

A nuanced understanding of market segmentation is essential to charting strategic priorities within the pharmaceutical equipment sector. When examining equipment types, one must consider aseptic processing equipment, blister packaging machines, capsule filling equipment, chromatography instruments, fermenters and bioreactors, fluid bed dryers, granulators, liquid filling machines, lyophilizers, mixers, and tablet processing systems, with tablet coating machines and tablet presses forming critical subcategories. Technology segmentation further distinguishes between reusable equipment-valued for its longevity and cost amortization-and single use equipment, which provides flexibility and reduced cleaning validation burdens.

End users span contract manufacturing organizations that deliver turnkey production services, pharmaceutical companies driving in-house manufacturing, research and academic institutes fostering early-stage innovation, and specialized research institutes focusing on advanced therapeutics. Application segmentation highlights the breadth of use cases, extending from aseptic filling operations to biopharmaceutical manufacturing, oral liquid production, parenteral processing, and solid dosage form creation. This layered segmentation framework reveals that demand drivers vary significantly by category: bioreactor and single-use mixer uptake is strongest in the biopharma segment, whereas granulators and tablet presses remain mainstays for solid dose players.

By aligning product development roadmaps with these segment dynamics, equipment providers can prioritize feature sets and geographic roll-out strategies that resonate most powerfully within each niche. Moreover, end users can tailor capital investments and maintenance programs according to the risk profile and regulatory intensity associated with their core applications.

Regional Market Intelligence Illuminating Growth Drivers and Strategic Opportunities across the Americas, EMEA, and Asia-Pacific Landscapes

Regional dynamics play a defining role in shaping the pharmaceutical manufacturing equipment sector's trajectory. In the Americas, strong biopharmaceutical R&D pipelines and government incentives for domestic production have stimulated robust demand for single use bioreactors, chromatography systems, and lyophilization platforms. Key hubs in North America are also leveraging advanced analytics and automation to modernize legacy facilities, thereby extending equipment lifecycles and reducing operational expenditures.

The Europe, Middle East & Africa region exhibits a more diverse set of drivers. Western European markets continue to lead in continuous processing adoption and integration of industry 4.0 solutions, supported by stringent regulatory regimes that emphasize quality by design. In contrast, emerging markets across the Middle East and Africa are investing in blister packaging and liquid filling lines to meet growing generic drug demand, with local regulatory bodies gradually strengthening manufacturing standards to align with global best practices.

Asia-Pacific stands out for its rapid capacity additions and cost-competitive manufacturing base. Countries such as India and China are scaling up granulators, tablet presses, and fluid bed dryers to serve both domestic and export markets. Simultaneously, regional governments are offering incentives for advanced bioreactor installations and funding collaborative centers of excellence. Connectivity initiatives are also fostering cross-border partnerships that accelerate technology transfer and localize after-sales support.

Identifying Leading Pharmaceutical Manufacturing Equipment Providers and Their Strategic Initiatives Shaping Industry Competitiveness

Leading equipment providers are differentiating themselves through a mix of organic innovation, strategic partnerships, and targeted acquisitions. Several global firms have expanded their single-use portfolio by acquiring niche manufacturers of sterile connectors and filtration units, thereby offering end users more comprehensive plug-and-play solutions. Others have invested in digital twins and cloud-enabled monitoring platforms, allowing process engineers to simulate scale-up scenarios and troubleshoot equipment performance without physical trials.

Collaborations between technology specialists and research institutions are also on the rise, resulting in co-developed chromatography resins and advanced sensor arrays that deliver tighter process control. Meanwhile, certain legacy suppliers have focused on modular skid-based systems, enabling contract manufacturers to rapidly configure production lines for new molecule launches. Service differentiation has become equally important, with firms offering predictive maintenance contracts and embedded remote diagnostics that proactively address equipment health issues.

Competition is further intensified by emerging players from adjacent industries, such as semiconductor equipment vendors entering the bioprocessing space with precision fluidics and contamination control expertise. This dynamic landscape underscores the importance of agility, with top performers continually refining their go-to-market strategies and leveraging cross-segment insights to anticipate customer needs.

Actionable Strategies and Best Practices for Industry Leaders to Enhance Operational Agility and Drive Sustainable Growth

Industry leaders should prioritize flexibility and digital integration to remain competitive. Investing in modular, single-use systems can reduce validation cycles and enable rapid changeover between product lines, supporting a shift toward personalized therapies. Complementing hardware upgrades with advanced process control software will provide real-time visibility into critical parameters, allowing teams to preempt deviations and maintain consistent output quality.

Diversifying supply chains is equally essential in the current geopolitical climate. Establishing partnerships with regional equipment assemblers and adopting equipment-as-a-service models can mitigate exposure to tariffs and logistical disruptions. Additionally, engaging early with regulatory authorities to align on process analytical technology roadmaps can streamline approvals and reduce post-approval modifications.

Finally, fostering cross-functional collaboration between R&D, engineering, and operations teams will accelerate technology adoption and drive continuous improvement. By embedding a culture of innovation, organizations can harness data insights to refine workflows, optimize utility consumption, and scale capacity efficiently. This holistic approach balances cost discipline with agility, positioning firms to capitalize on emerging therapeutic trends and evolving market demands.

Comprehensive Research Approach Detailing Data Collection, Validation, and Analytical Methods Underpinning Study Credibility

This study was developed through a rigorous research framework combining primary interviews, secondary data analysis, and quantitative validation techniques. Expert discussions with process engineers, quality assurance managers, and procurement directors provided firsthand insights into equipment performance, maintenance practices, and strategic investment drivers. Supplementing these interviews, an extensive review of industry publications, technical specifications, and regulatory guidelines ensured a comprehensive understanding of market trends.

Data triangulation methods were applied to corroborate findings across multiple sources. Equipment shipment records, patent filings, and academic research outputs were cross-referenced to confirm technology adoption timelines. Furthermore, a structured scoring model evaluated vendor capabilities against criteria such as innovation pipeline strength, service network coverage, and digital platform maturity. This model enabled objective comparisons and highlighted areas of competitive differentiation.

Throughout the process, quality controls were maintained via iterative peer reviews and validation checkpoints. Analysts continuously refined assumptions, updated contextual factors, and solicited feedback from advisory board members with deep domain expertise. The result is a robust and transparent methodology that underpins the study's strategic recommendations and ensures actionable intelligence for decision makers.

Conclusive Insights Summarizing Key Findings and Strategic Implications for Global Pharmaceutical Equipment Stakeholders

This executive summary has highlighted the critical role of advanced pharmaceutical manufacturing equipment in supporting robust and efficient drug production. By exploring transformative trends-from automation and single-use technologies to trade policy impacts-industry stakeholders can better navigate an increasingly complex landscape. Segmentation analysis has illuminated distinct demand profiles across equipment types, technology preferences, end-user categories, and application areas, underscoring the need for tailored strategies.

Regional insights reveal that the Americas, EMEA, and Asia-Pacific each present unique growth drivers and challenges, whether it be biopharma innovation clusters, regulatory harmonization efforts, or cost-competitive capacity expansions. Competitive intelligence underscores the importance of strategic partnerships, digital service offerings, and modular system architectures in differentiating vendor propositions. Finally, actionable recommendations emphasize flexibility, supply chain diversification, and data-driven process control as key enablers of sustainable growth.

Armed with these findings, equipment providers and end users alike can make informed decisions that balance operational efficiency with technological agility. Embracing a holistic approach to equipment strategy will be essential to unlocking new opportunities, managing risk, and achieving long-term success in the evolving pharmaceutical manufacturing ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Manufacturing Equipment Market, by Equipment Type

  • 8.1. Aseptic Processing Equipment
  • 8.2. Blister Packaging Machines
  • 8.3. Capsule Filling Equipment
  • 8.4. Chromatography Equipment
  • 8.5. Fermenters & Bioreactors
  • 8.6. Fluid Bed Dryers
  • 8.7. Granulators
  • 8.8. Liquid Filling Machines
  • 8.9. Lyophilizers
  • 8.10. Mixers
  • 8.11. Tablet Processing Equipment
    • 8.11.1. Tablet Coating Machine
    • 8.11.2. Tablet Press

9. Pharmaceutical Manufacturing Equipment Market, by Technology

  • 9.1. Reusable Equipment
  • 9.2. Single Use Equipment

10. Pharmaceutical Manufacturing Equipment Market, by End User

  • 10.1. Contract Manufacturing Organizations
  • 10.2. Pharmaceutical Companies
  • 10.3. Research & Academic Institutes
  • 10.4. Research Institutes

11. Pharmaceutical Manufacturing Equipment Market, by Application

  • 11.1. Aseptic Filling
  • 11.2. Biopharmaceutical Manufacturing
  • 11.3. Oral Liquid Manufacturing
  • 11.4. Parenteral Manufacturing
  • 11.5. Solid Dosage Manufacturing

12. Pharmaceutical Manufacturing Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Pharmaceutical Manufacturing Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Pharmaceutical Manufacturing Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Pharmaceutical Manufacturing Equipment Market

16. China Pharmaceutical Manufacturing Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. ACG Pvt. Ltd.
  • 17.6. ACIC Pharmaceuticals Inc.
  • 17.7. Alfa Laval AB
  • 17.8. Ambica Pharma Machines Pvt. Ltd.
  • 17.9. GEA Group Aktiengesellschaft
  • 17.10. Glatt GmbH
  • 17.11. IDEX Corporation
  • 17.12. IMA Group
  • 17.13. Jinhu Ginhong Machinery Co., Ltd.
  • 17.14. Komachine Inc.
  • 17.15. Korber AG
  • 17.16. Lee Industries
  • 17.17. Maquinaria Industrial Dara, S.L.
  • 17.18. Marchesini Group S.p.A.
  • 17.19. MG2 s.r.l.
  • 17.20. Niverplast B.V.
  • 17.21. Paul Mueller Company
  • 17.22. Romaco Group
  • 17.23. Shinva Medical Instrument Co., Ltd.
  • 17.24. Solvay S.A.
  • 17.25. Syntegon Technology GmbH
  • 17.26. Thermo Fisher Scientific Inc.
  • 17.27. UNITED PHARMATEK LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 162. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)